AstraZeneca upbeat on latest Farxiga trial results
28th Jul 2020 08:38
(Sharecast News) - AstraZeneca said on Tuesday that high-level results from the phase 3 'DAPA-CKD- trial of 'Farxiga', or dapagliflozin, showed a "statistically significant and clinically meaningful" effect on its primary endpoint.
Read moreModerna starts dosing patients for phase III Covid-19 vaccine clinical trial
27th Jul 2020 12:29
(Sharecast News) - Moderna has started to dose patients in its 30,000-strong phase three clinical trial of its Covid-19 vaccine candidate, mRNA-1273.
Read moreAstraZeneca gets two EMA recommendations, enters oncology partnership
27th Jul 2020 08:16
(Sharecast News) - AstraZeneca shareholders were met with a raft of updates from the company on Monday morning, including two positive recommendations from the European Medicines Agency, and the announcement of a new oncology collaboration.
Read moreIsraeli researchers believe treatment might sharply reduce Covid-19 symptoms
27th Jul 2020 08:05
(Sharecast News) - Israeli researchers have claimed that an off-the-shelf treatment may possibly reduce the symptoms from Covid-19 to those of the common cold.
Read moreAstraZeneca gets approval for COPD treatment in US
24th Jul 2020 07:27
(Sharecast News) - AstraZeneca announced on Friday that 'Breztri Aerosphere', or budesonide, glycopyrrolate and formoterol fumarate, has been approved in the United States for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read moreOxford University's Gilbert says vaccine rollout possible by Xmas, but not certain
21st Jul 2020 15:09
(Sharecast News) - The lead researcher in Oxford University's push to find a Covid-19 vaccine alongside AstraZeneca cautioned on Tuesday that there could be no certainty that it could be rolled out by Christmas - although it was possible.
Read moreJP Morgan stay 'overweight' on AstraZeneca despite 'aggressive' rise in shares
21st Jul 2020 13:51
(Sharecast News) - JP Morgan analysts reiterated their 'overweight' stance and 9,500.0p target price on shares of AstraZeneca following the release of early clinical trial data for its Covid-19 vaccine candidate, AZD1222, the day before.
Read moreTuesday broker round-up
21st Jul 2020 12:58
(Sharecast News) - Premier Oil: Peel Hunt upgrades to buy with a target price of 50.0p.
Read moreEurope open: Stocks reverse early losses, healthcare leads
20th Jul 2020 07:56
(Sharecast News) - Stocks have recovered from early selling following news that European Union leaders meeting in Brussels had made progress on the terms for a reconstruction fund.
Read moreOxford-AstraZeneca Covid-19 vaccine safe, produces immune response
20th Jul 2020 07:52
(Sharecast News) - The coronavirus vaccine being developed by AstraZeneca and the University of Oxford was found to produce both antibodies and T-cells and to be "safe, tolerated, and immunogenic", according to results of a phase 1 human trial published in The Lancet on Monday.
Read moreUK government secures 90 million doses of Covid-19 vaccines
20th Jul 2020 07:51
(Sharecast News) - The UK government has agreed to buy 90 million doses of coronavirus vaccines being developed by Pfizer and Biontech, and France's Valneva.
Read moreAstraZeneca Covid-19 vaccine shows promise - report
15th Jul 2020 11:42
(Sharecast News) - A Covid-19 vaccine backed by AstraZeneca is producing positive results in initial trials, according to a report.
Read moreJP Morgan says 'pent-up' demand will be exhausted, stays 'overweight' on Tech and Healthcare
13th Jul 2020 12:48
(Sharecast News) - Equity strategists at JP Morgan believe that second quarter corporate results on both sides of the Atlantic may come in ahead of analysts' forecasts, helped by the fact that estimates were at very depressed levels.
Read moreAstraZeneca gets EU approval for Lynparza
8th Jul 2020 07:18
(Sharecast News) - AstraZeneca announced on Wednesday, alongside its partner MSD, that 'Lynparza', or olaparib, has been approved in the European Union for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.
Read moreInovio Pharmaceuticals's Covid-19 vaccine triggers immune response
30th Jun 2020 18:34
(Sharecast News) - Inovio Pharmaceuticals's experimental vaccine against the novel coronavirus was found to be safe in an early stage clinical trial and successfully induced an immune response in the majority of participants in the test.
Read more